We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MKC icon
376
McCormick & Company Non-Voting
MKC
$14B
$4.94M 0.03%
59,553
-232,344
-80% -$18.7M
IR icon
377
Ingersoll Rand
IR
$33.1B
$4.83M 0.03%
92,393
+19,371
+27% +$989K
KFY icon
378
Korn Ferry
KFY
$4.31B
$4.82M 0.03%
95,220
+73,644
+341% +$3.91M
PEG icon
379
Public Service Enterprise Group
PEG
$38.7B
$4.81M 0.03%
78,571
-7,549
-9% -$438K
GM icon
380
General Motors
GM
$80.9B
$4.81M 0.03%
142,956
+36,191
+34% +$1.34M
GMED icon
381
Globus Medical
GMED
$11.1B
$4.8M 0.03%
64,574
-15,000
-19% -$1.02M
BCC icon
382
Boise Cascade
BCC
$2.73B
$4.75M 0.03%
69,130
+2,232
+3% +$152K
WMB icon
383
Williams Companies
WMB
$85.8B
$4.69M 0.03%
142,435
-16,745
-11% -$545K
RNAM
384
DELISTED
Avidity Biosciences
RNAM
$4.68M 0.03%
211,067
– –
ENTA icon
385
Enanta Pharmaceuticals
ENTA
$362M
$4.68M 0.03%
100,507
– –
ZWS icon
386
Zurn Elkay Water Solutions
ZWS
$8.6B
$4.67M 0.03%
220,652
+30,251
+16% +$714K
FATE icon
387
Fate Therapeutics
FATE
$275M
$4.65M 0.03%
460,436
– –
CME icon
388
CME Group
CME
$95.4B
$4.64M 0.03%
27,580
+2,511
+10% +$436K
ALGN icon
389
Align Technology
ALGN
$12.9B
$4.63M 0.03%
21,958
+3,101
+16% +$621K
INBX
390
DELISTED
Inhibrx, Inc. Common Stock
INBX
$4.61M 0.03%
187,069
-100,000
-35% -$2.94M
VTR icon
391
Ventas
VTR
$47.5B
$4.6M 0.03%
102,174
-27,323
-21% -$1.15M
K
392
DELISTED
Kellanova
K
$4.6M 0.03%
68,744
+15,935
+30% +$1.08M
HIG icon
393
Hartford Financial Services
HIG
$39.9B
$4.59M 0.03%
60,522
+5,770
+11% +$415K
GMAB icon
394
Genmab
GMAB
$17.5B
$4.58M 0.03%
108,138
-14,373
-12% -$592K
HAL icon
395
Halliburton
HAL
$26.1B
$4.56M 0.03%
115,938
+11,116
+11% +$393K
CAG icon
396
Conagra Brands
CAG
$7.42B
$4.56M 0.03%
117,752
+37,184
+46% +$1.35M
EXC icon
397
Exelon
EXC
$48.1B
$4.5M 0.03%
104,152
-4,482
-4% -$177K
TRN icon
398
Trinity Industries
TRN
$2.92B
$4.45M 0.03%
+150,663
New +$4.2M
CMG icon
399
Chipotle Mexican Grill
CMG
$43.9B
$4.45M 0.03%
160,400
+13,650
+9% +$408K
CNI icon
400
Canadian National Railway
CNI
$78.5B
$4.45M 0.03%
37,448
+1,954
+6% +$234K
14 15
16
17 18

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.